Yeast, human stem cells drive discovery of new Parkinson's disease drug targets

Using a discovery platform whose components range from yeast cells to human stem cells, Whitehead Institute scientists have identified a novel Parkinson's disease drug target and a compound capable of repairing neurons derived from Parkinson's patients. The platform - whose effectiveness is described in dual papers published online this week in the journal Science - could accelerate the discovery of drug candidates that address the underlying pathology of Parkinson's and other neurodegenerative diseases. Today, no such drugs exist...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/aCNvy5si2IY/267939.php

sport news news auto sport